IP Library Granted Patent US 8,545,460
Granted Patent B2
US 8,545,460 · App. 11/380,124 · Granted Oct 1, 2013

Infusion apparatuses and related methods

Inventors: Jim C. Beasley (Phoenix, AZ); Kelly B. Powers (North Salt Lake, UT)
Assignee: C. R. Bard, Inc.
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 8,545,460
App. No.
11/380,124
Granted
Oct 1, 2013
Kind
B2
Abstract

Assemblies for identifying a power injectable vascular access port are described. One assembly includes a vascular access port, a first identifiable feature, a second identifiable feature, and a third identifiable feature. The first identifiable feature is incorporated into the access port and identifies the access port as suitable for flowing fluid at a fluid flow rate of at least 1 milliliter per second through the access port. The second identifiable feature is incorporated into the access port and identifies the access port as suitable for accommodating a pressure within the cavity of at least 35 psi. The third identifiable feature is separated from the access port and confirms that the implanted access port is both suitable for flowing fluid at a rate of at least 1 milliliter per second through the access port and for accommodating a pressure within the cavity of at least 35 psi.

Claims (7)

1. A system for identifying a power injectable vascular access port, comprising:

a vascular access port comprising a body defining a cavity, a septum, and an outlet in communication with the cavity;

a first identifiable feature incorporated into the access port perceivable following subcutaneous implantation of the access port, the first feature comprising a radiographic marker identifying the access port as suitable for flowing fluid at a fluid flow rate of at least 1 milliliter per second through the access port; and

a second identifiable feature separated from the subcutaneously implanted access port, the second feature visually observable following subcutaneous implantation to confirm that the implanted access port is suitable for flowing fluid at a rate of at least 1 milliliter per second through the access port.

2. The system according to claim 1 , wherein the second identifiable feature comprises visually perceptible information provided on an element selected from the group consisting essentially of a key chain, a bracelet, a wrist band, a sticker provided on a patient's chart, a patient ID card, a label provided on packaging of the access port, and combinations thereof.

3. The system according to claim 1 , wherein the second identifiable feature is included on an infusion set couplable to the vascular access port.

4. The system according to claim 1 , wherein the radiographic marker is selected from the group consisting essentially of an observable pattern, a symbol, a typographical character, an indicium, and combinations thereof.

Assignments (3)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jul 20, 2017
From: C. R. BARD, INC.
To: BARD PERIPHERAL VASCULAR, INC.
Reel/Frame 043058/0522 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded May 21, 2013
From: SHEETZ, KEVIN W.; BURNSIDE, EDDIE K.
To: C. R. BARD, INC.
Reel/Frame 030460/0913 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jul 21, 2006
From: BEASLEY, JIM C.; STATS, JASON R.; HAMATAKE, BRET; ROME, GUY T.; WEIR, STEVEN A.; POWERS, KELLY B.; EVANS, JOHN G.; HIBDON, DWIGHT; GERONDALE, JAY D.
To: C.R. BARD, INC.
Reel/Frame 018117/0806 →
Continuity (3)
Provisional Application 60737466 · Nov 15, 2005
Provisional Application 60675309 · Apr 27, 2005
Related Publication 20060264898A1 · Nov 23, 2006